BIRC5 and hepatocellular carcinoma: In hepatocellular carcinoma cells, niclosamide inhibits cell viability, clone formation, and induces apoptosis by deactivating STAT3 phosphorylation and downregulating antiapoptotic proteins, Mcl-1, and survivin [27].